Patients with moderate chronic kidney disease without heart disease have reduced coronary flow velocity reserve
| Autor: | Gregor Guron, Cecilia Wallentin Guron, Pavlos Kashioulis, Ola Hammarsten, Maria Svensson, Aso Saeed |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Cardio-renal syndrome
medicine.medical_specialty Heart disease Heart Diseases 030204 cardiovascular system & hematology Doppler echocardiography Left ventricular hypertrophy Ventricular Function Left 03 medical and health sciences Ventricular Dysfunction Left 0302 clinical medicine Cardio-Renal Syndrome Internal medicine Chronic kidney disease medicine Diseases of the circulatory (Cardiovascular) system Humans Left atrial volume Cardiac and Cardiovascular Systems 030212 general & internal medicine Renal Insufficiency Chronic Isovolumetric contraction Ejection fraction Kardiologi medicine.diagnostic_test business.industry medicine.disease Coronary flow velocity reserve Cross-Sectional Studies Heart failure RC666-701 Cardiology Diastolic dysfunction Cardio‐renal syndrome Cardiology and Cardiovascular Medicine business Kidney disease |
| Zdroj: | ESC Heart Failure, Vol 7, Iss 5, Pp 2797-2806 (2020) |
| Popis: | AIMS: The overall aim was to identify sub-clinical cardiac abnormalities by echocardiography in patients with chronic kidney disease (CKD) stages 3 and 4 and to investigate underlying mechanisms. METHODS AND RESULTS: Ninety-one patients with CKD stages 3 and 4, without a diagnosis of heart disease, and 41 healthy matched controls were included in this cross-sectional study. Cardiac morphology and function were analysed with Doppler echocardiography and coronary flow velocity reserve (CFVR) in response to adenosine was measured in the left anterior descendent artery to detect coronary microvascular dysfunction (CMD). All study subjects had a left ventricular (LV) ejection fraction > 50%. Patients with CKD showed statistically significant increases in left atrial volume index and transmitral and pulmonary vein flow velocities during atrial contraction and prolonged LV isovolumetric relaxation time. Patients with CKD had significantly reduced CFVR vs. controls (2.74 ± 0.86 vs. 3.40 ± 0.89, P < 0.001), and 43% of patients were classified as having CMD compared with 9% of controls (P = 0.001). CONCLUSIONS: Patients with CKD stages 3 and 4, without a diagnosis of heart disease, showed early abnormalities in LV diastolic function that did not fulfil the criteria for LV dysfunction according to current guidelines. A large proportion of CKD patients had CMD, suggesting that microvascular abnormalities may have a pathogenic role in the development of heart failure in this patient group. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|